Paul has almost 20 years of experience in the IP profession with clients ranging from universities and SMEs to large multinational companies particularly in the biotechnology, chemistry and pharmaceutical fields. He has significant expertise in biologics including antibody technology, stem cells, RNAi and vaccines.
